4’-Epidoxorubicin
56390-09-1
580.0
C27H29NO11 • HCl
DMSO, Water
-20°C
Cell-permeable. An anthracycline antitumor antibiotic. A stereoisomer of doxorubicin (Cat. No. 1527-5) that exhibits reduced cardiotoxicity. Its antitumor actions are mediated by targeting topoisomerase II.
0.1 lbs
Substance Name:N-Debenzoyl-N-(t-butoxycarbonyl)-10-deacetyltaxol; Taxotere; RP-56976; NSC-628503
CAS Number:114977-28-5
Substance Name:3,8-Dihydroxy-6H-dibenzo[b,d]pyran-6-one; 2',7-Dihydroxy-3,4-benzocoumarin
CAS Number:1143-70-0
Substance Name:3,8-Dihydroxy-6H-dibenzo[b,d]pyran-6-one; 2',7-Dihydroxy-3,4-benzocoumarin
CAS Number:1143-70-0
Substance Name:N-Debenzoyl-N-(t-butoxycarbonyl)-10-deacetyltaxol; Taxotere; RP-56976; NSC-628503
CAS Number:114977-28-5
Substance Name:5-Amino-7-(cyclohexylamino)-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
Substance Name:3,8-Dihydroxy-6H-dibenzo[b,d]pyran-6-one; 2',7-Dihydroxy-3,4-benzocoumarin
CAS Number:1143-70-0